Juvederm Voluma XC Interactions
There are 572 drugs known to interact with Juvederm Voluma XC (hyaluronan / lidocaine), along with 7 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 37 are major, 430 are moderate, and 105 are minor.
- View all 572 medications that may interact with Juvederm Voluma XC
- View Juvederm Voluma XC alcohol/food interactions (2)
- View Juvederm Voluma XC disease interactions (7)
Most frequently checked interactions
View interaction reports for Juvederm Voluma XC (hyaluronan / lidocaine) and the medicines listed below.
- acetaminophen / chlorpheniramine / phenylephrine
- acetazolamide
- Actisite (tetracycline)
- Advil (ibuprofen)
- Afinitor Disperz (everolimus)
- Alcohol (contained in alcoholic beverages) (ethanol)
- aluminum hydroxide / magnesium hydroxide / simethicone
- aspirin
- azelastine nasal
- Azilect (rasagiline)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- bimatoprost topical
- bisoprolol
- Botox Cosmetic (onabotulinumtoxinA)
- brimonidine ophthalmic
- budesonide
- caffeine
- calcitonin
- Carafate (sucralfate)
- Cardizem CD (diltiazem)
- Cardura (doxazosin)
- chlorzoxazone
- Cipro XR (ciprofloxacin)
- Clomid (clomiphene)
- clonazepam
- clonidine
- Combivent Respimat (albuterol / ipratropium)
- Copaxone (glatiramer)
Juvederm Voluma XC alcohol/food interactions
There are 2 alcohol/food interactions with Juvederm Voluma XC (hyaluronan / lidocaine).
Juvederm Voluma XC disease interactions
There are 7 disease interactions with Juvederm Voluma XC (hyaluronan / lidocaine) which include:
- cardiovascular dysfunction
- hepatic dysfunction
- renal dysfunction
- seizures
- sinus/AV node dysfunction
- electrolyte imbalance
- bleeding disorders
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.